Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure allows for selective modification in drug design, making it valuable in creating compounds with improved metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing fluorinated benzylamine derivatives, which are found in certain central nervous system agents and anti-inflammatory drugs. The tert-butyloxycarbonyl (Boc) protecting group facilitates stepwise synthesis by shielding the amine functionality during reactions, enabling controlled deprotection under mild acidic conditions later in the synthetic pathway.